Authors
Loading...
Economic analysis reports a 6.9 percent rise in U.S. health spending to 2.0 trillion dollars in 2005, highlighting a third consecutive year of decelerating growth driven by prescription drug costs.
Catlin et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: